We are live on ! Find out more
PJP icon

Invesco Pharmaceuticals ETF
PJP

119 hedge funds and large institutions have $151M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 11

118% more capital invested

Capital invested by funds: $69.2M → $151M (+$81.8M)

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

15.89% more ownership

Funds ownership: 21.99% → 37.88% (+16%)

13% more funds holding

Funds holding: 105 → 119 (+14)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $259K

Holders
119
Holders Change
+14
Holders Change %
+13.33%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
33
Reduced
21
Closed
11
Calls
–
Puts
$259K
Net Calls
-$259K
Net Calls Change
-$259K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$24.4M
2
HighTower Advisors
HighTower Advisors
Illinois
+$23.4M
3
Bank of America
Bank of America
North Carolina
+$5.51M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$5.45M
5
CI
Cavalier Investments
Georgia
+$4.85M

Top Sellers

Rank Fund Capital Flow
1
WI
WBI Investments
New Jersey
-$739K
2
IDA
Intelligence Driven Advisers
California
-$565K
3
HAS
HBW Advisory Services
California
-$533K
4
GC
Grimes & Company
Massachusetts
-$502K
5
BlackRock
BlackRock
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
26
Gilpin Wealth Management
Colorado
$718K -$11.2K -106 -2%
Jones Financial Companies
27
Jones Financial Companies
Missouri
$655K +$31.9K +302 +5%
FHA
28
Flagship Harbor Advisors
Massachusetts
$628K – – –
PAG
29
Private Advisor Group
New Jersey
$610K +$621K +5,877 New
Stifel Financial
30
Stifel Financial
Missouri
$596K +$607K +5,747 New
P
31
&Partners
Tennessee
$517K +$171K +1,617 +48%
IFG
32
Independent Financial Group
California
$510K +$520K +4,919 New
Focus Partners Wealth
33
Focus Partners Wealth
Massachusetts
$486K -$89.4K -846 -15%
SWGC
34
Summit Wealth Group (Colorado)
Colorado
$442K +$951 +9 +0.2%
CIAS
35
Capital Investment Advisory Services
North Carolina
$438K -$4.22K -40 -0.9%
WTC
36
WhitTier Trust Company
Nevada
$424K – – –
DE
37
Diversified Enterprises
Delaware
$422K +$211 +2 +0%
PFS
38
Prospera Financial Services
Texas
$393K +$400K +3,785 New
SQA
39
Simon Quick Advisors
New Jersey
$384K +$391K +3,700 New
EH
40
Equitable Holdings
New York
$372K -$18.5K -175 -5%
NHC
41
Nicholas Hoffman & Company
Georgia
$361K – – –
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$360K -$3.91K -37 -1%
GCP
43
GSA Capital Partners
United Kingdom
$357K +$82.2K +778 +29%
RIA
44
Realta Investment Advisors
Delaware
$349K +$347K +3,289 +4,385%
EW
45
Element Wealth
Mississippi
$344K – – –
USCWA
46
U.S. Capital Wealth Advisors
Texas
$324K +$330K +3,126 New
MWM
47
MinichMacGregor Wealth Management
New York
$320K +$326K +3,083 New
IMC Chicago
48
IMC Chicago
Illinois
$318K +$324K +3,069 New
WSC
49
Wellington Shields & Co
New York
$316K +$321K +3,043 New
MIC
50
Means Investment Company
Maine
$305K -$36.3K -344 -10%
1
2
3 4 5

PJP Hedge Fund Activity: Q1 2026 in Review

119 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2026, worth a combined $151M — up 118% from $69.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PJP positions and 11 closed out — a net gain of 17 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was WBI Investments, exiting entirely with an estimated $739K sold.

  • 119 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2026, up from 105 in Q4 2025.
  • Funds reported $151M of Invesco Pharmaceuticals ETF stock for Q1 2026, up 118% quarter-over-quarter.
  • 28 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2026 and 11 closed out, a net change of +17 holders.
  • The largest Invesco Pharmaceuticals ETF buyer in Q1 2026 was Morgan Stanley, an estimated $24.4M added.
  • The largest Invesco Pharmaceuticals ETF seller in Q1 2026 was WBI Investments, an estimated $739K sold.

Based on aggregated 13F filings for Q1 2026.